BR112015023558A2 - métodos para a síntese de esfingomielinas e dihidroesfingomielinas - Google Patents

métodos para a síntese de esfingomielinas e dihidroesfingomielinas

Info

Publication number
BR112015023558A2
BR112015023558A2 BR112015023558A BR112015023558A BR112015023558A2 BR 112015023558 A2 BR112015023558 A2 BR 112015023558A2 BR 112015023558 A BR112015023558 A BR 112015023558A BR 112015023558 A BR112015023558 A BR 112015023558A BR 112015023558 A2 BR112015023558 A2 BR 112015023558A2
Authority
BR
Brazil
Prior art keywords
synthesis
methods
dihydrosphingomyelin
sphingomyelin
present
Prior art date
Application number
BR112015023558A
Other languages
English (en)
Inventor
Peer Andreas
Oswald Benoit
Carmen Oniciu Daniela
Gonzalez Miguel
Sauter Patrik
Rebmann Peter
Heckhoff Stefan
Original Assignee
Cerenis Therapeutics Holding Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerenis Therapeutics Holding Sa filed Critical Cerenis Therapeutics Holding Sa
Publication of BR112015023558A2 publication Critical patent/BR112015023558A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/141—Esters of phosphorous acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/24—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/10—Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/02—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of compounds containing imino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/113—Esters of phosphoric acids with unsaturated acyclic alcohols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

resumo “métodos para a síntese de esfingomielinas e dihidroesfingomielinas” a presente invenção inclui métodos para a síntese de esfingomielinas e dihidroesfingomielinas. a presente invenção também inclui métodos para a síntese de esfingosinas e dihidroesfingosinas. a presente invenção inclui ainda métodos para a síntese de ceramidas e dihidroceramidas.
BR112015023558A 2013-03-15 2014-03-14 métodos para a síntese de esfingomielinas e dihidroesfingomielinas BR112015023558A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361801641P 2013-03-15 2013-03-15
EP13306056 2013-07-23
PCT/IB2014/000494 WO2014140787A2 (en) 2013-03-15 2014-03-14 Methods for the synthesis of sphingomyelins and dihydrosphingomyelins

Publications (1)

Publication Number Publication Date
BR112015023558A2 true BR112015023558A2 (pt) 2017-07-18

Family

ID=51538203

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015023558A BR112015023558A2 (pt) 2013-03-15 2014-03-14 métodos para a síntese de esfingomielinas e dihidroesfingomielinas

Country Status (15)

Country Link
US (3) US20140316154A1 (pt)
EP (3) EP3842443A1 (pt)
JP (2) JP6438417B2 (pt)
KR (1) KR20150132188A (pt)
CN (1) CN105051051B (pt)
AU (2) AU2014229638B2 (pt)
BR (1) BR112015023558A2 (pt)
CA (1) CA2900902C (pt)
DK (1) DK3363805T3 (pt)
HK (2) HK1212705A1 (pt)
MX (1) MX2015012877A (pt)
PH (1) PH12015501835A1 (pt)
SG (2) SG10201804887YA (pt)
WO (1) WO2014140787A2 (pt)
ZA (1) ZA201505860B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2396017T1 (sl) 2009-02-16 2015-12-31 Cerenis Therapeutics Holding Sa Mimika apolipoproteina A-1
SG10201708237SA (en) 2010-10-18 2017-11-29 Cerenis Therapeutics Holding Sa Compounds, compositions and methods useful for cholesterol mobilisation
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
EP3842443A1 (en) * 2013-03-15 2021-06-30 Cerenis Therapeutics Holding SA Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
US20190048049A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding Sa Cargomers
WO2019030575A1 (en) 2017-08-10 2019-02-14 Cerenis Therapeutics Holding APOMÈRES
CN111757886A (zh) * 2018-03-27 2020-10-09 日油株式会社 鞘磷脂衍生的脂质及其生产方法
JP7303618B2 (ja) * 2018-10-05 2023-07-05 日本精化株式会社 スフィンゴリン脂質前駆体及びその製造方法、並びに、スフィンゴリン脂質の製造方法
KR20230004606A (ko) 2020-04-16 2023-01-06 아비오닉스 파마 에스에이 신장 질환을 치료하기 위한 cer-001 요법
WO2021209808A1 (en) 2020-04-16 2021-10-21 Abionyx Pharma Sa Cer-001 therapy for treating kidney disease
AU2021256086A1 (en) 2020-04-16 2022-12-15 Abionyx Pharma Sa Methods for treating acute conditions using lipid binding protein- based complexes
WO2022069942A2 (en) 2020-10-01 2022-04-07 Abionyx Pharma Sa Methods for treating eye diseases using lipid binding protein-based complexes
MX2023012223A (es) 2021-04-15 2023-10-26 Abionyx Pharma Sa Uso de complejos a base de proteinas de union a lipidos en soluciones de conservacion de organos.
WO2023194797A1 (en) 2022-04-06 2023-10-12 Abionyx Pharma Sa Methods for treating eye diseases using lipid binding protein-based complexes
WO2023194798A1 (en) 2022-04-06 2023-10-12 Abionyx Pharma Sa Methods for treating leukocytosis, endothelial dysfunction and carditis using lipid binding protein-based complexes
WO2023237927A2 (en) 2022-06-10 2023-12-14 Abionyx Pharma Sa Methods for treating hyperinflammatory conditions using lipid binding protein -based complexes
WO2023237935A2 (en) 2022-06-10 2023-12-14 Abionyx Pharma Sa Methods for treating acute conditions using lipid binding protein-based complexes
WO2024003612A2 (en) 2022-06-28 2024-01-04 Abionyx Pharma Sa Compounds and processes for the synthesis of sphingomyelins
WO2024150064A1 (en) 2023-01-13 2024-07-18 Abionyx Pharma Sa Lipid binding protein molecule therapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146810A3 (de) 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US5220043A (en) * 1991-03-21 1993-06-15 Ohio University Synthesis of D-erythro-sphingomyelins
US5766627A (en) 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
JP3002702B2 (ja) 1993-11-16 2000-01-24 スカイファーム インコーポレーテッド 活性物質の制御放出を有する小胞
WO1999041266A1 (en) 1998-02-12 1999-08-19 Emory University Sphingolipid derivatives and their methods of use
JP2004002215A (ja) * 2002-05-23 2004-01-08 National Institute Of Advanced Industrial & Technology スフィンゴ脂質誘導体の製造方法
JP2007517860A (ja) 2004-01-15 2007-07-05 バイオラブ・リミテッド スフィンゴミエリン、その中間体及びその調製方法
EP1750673B1 (en) 2004-05-17 2009-12-02 Tekmira Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
ATE417607T1 (de) * 2004-06-29 2009-01-15 Jado Technologies Gmbh Sphingolipide gegen krankhafte prozesse in lipid rafts
JP4825947B2 (ja) 2004-08-04 2011-11-30 学校法人関西学院 不飽和アミノジオール類の製造方法
JP2006045113A (ja) 2004-08-04 2006-02-16 Kemikurea:Kk リン酸エステル類
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US7470664B2 (en) * 2005-07-20 2008-12-30 Merck & Co., Inc. HCV NS3 protease inhibitors
JP2007204384A (ja) 2006-01-31 2007-08-16 Kemikurea:Kk 光学活性リン酸誘導体およびこれを用いた光学活性スフィンゴシン１−リン酸誘導体の製造方法
JP5429734B2 (ja) * 2007-02-09 2014-02-26 国立大学法人岐阜大学 スフィンゴ糖脂質の合成法
US8093395B2 (en) 2007-03-09 2012-01-10 Otsuka Chemical Co., Ltd. Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
US20110250266A1 (en) 2008-10-07 2011-10-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Liposomal systems comprising sphingomyelin
RU2017126088A (ru) 2011-02-07 2019-01-31 Серени Терапеутикс Холдинг С.А. Липопротеиновые комплексы и их получение и применения
FR3000959B1 (fr) * 2013-01-14 2015-08-21 Holis Technologies Nouveaux intermediaires de synthese permettant d'acceder avec de bons rendements a des derives de sphingosines, ceramides et sphingomyelines
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
EP3842443A1 (en) 2013-03-15 2021-06-30 Cerenis Therapeutics Holding SA Methods for the synthesis of sphingomyelins and dihydrosphingomyelins

Also Published As

Publication number Publication date
ZA201505860B (en) 2017-11-29
JP2018168171A (ja) 2018-11-01
AU2014229638B2 (en) 2018-09-06
CN105051051A (zh) 2015-11-11
SG10201804887YA (en) 2018-07-30
WO2014140787A3 (en) 2015-03-26
JP2016511281A (ja) 2016-04-14
CA2900902C (en) 2022-08-02
KR20150132188A (ko) 2015-11-25
HK1212705A1 (zh) 2016-06-17
MX2015012877A (es) 2016-02-03
CN105051051B (zh) 2021-07-16
PH12015501835B1 (en) 2015-11-09
US20160075634A1 (en) 2016-03-17
JP6438417B2 (ja) 2018-12-12
SG11201506456VA (en) 2015-09-29
AU2018267598A1 (en) 2018-12-06
EP3363805A1 (en) 2018-08-22
EP2970344A2 (en) 2016-01-20
AU2014229638A1 (en) 2015-08-20
CA2900902A1 (en) 2014-09-18
HK1214266A1 (zh) 2016-07-22
US20140316154A1 (en) 2014-10-23
PH12015501835A1 (en) 2015-11-09
WO2014140787A2 (en) 2014-09-18
US9643915B2 (en) 2017-05-09
DK3363805T3 (da) 2021-03-08
US20170204122A1 (en) 2017-07-20
EP3842443A1 (en) 2021-06-30
EP3363805B1 (en) 2020-12-16

Similar Documents

Publication Publication Date Title
BR112015023558A2 (pt) métodos para a síntese de esfingomielinas e dihidroesfingomielinas
CR20150049A (es) Anticuerpos e inmunoconjugados anti-cd79b
CL2015002742A1 (es) Moléculas de unión para bcma y cd3.
CR20160257A (es) Anticuerpos e inmunoconjugados anti-cd33
CR20150482A (es) Anticuerpos e inmunoconjugados anti-b7-h4
BR112017027724A2 (pt) terapias de combinação para malignidades hematológicas com anticorpos anti-cd38 e inibidores de survivina
CR20150046A (es) Anticuerpos anti-cd79b e inmunoconjugados
BR112016000903A2 (pt) anticorpos
BR112016000106A2 (pt) anticorpos c1q do fator anti-complemento e usos dos mesmos
UY4175Q (es) Reloj pulsera
CR20150247A (es) Anticuerpos de antihemaglutinina y métodos de uso
PL2992538T3 (pl) Przekładnik wysokiego napięcia
GB2538638B (en) Turbomachine sparkplug fixing assembly
UY35463A (es) Formulaciones de polipéptido fc-factor ix.
IN2013MU00848A (pt)
AR097668A1 (es) Colorante-polímero
EP2970102A4 (en) IMPROVED PROCESS FOR THE SYNTHESIS OF MELPHALAN AND ITS SALT HYDROCHLORIDE
ZA201603457B (en) Novel method for the synthesis of agomelatine
BR112016014000A2 (pt) Síntese de enantiômero de progesterona e intermediários do mesmo
BR112012029626A2 (pt) processo para preparar ditianona-tetracarboxi-dimidas
PH12018500508A1 (en) Methods for the synthesis of spingomyelins and dihydrosphingomyelins
PL2875037T4 (pl) Sposób syntezy N-(fosfonometylo)glicyny
BR112018007282A2 (pt) métodos para síntese total de resolvina e1
DE112014003192A5 (de) Verfahren zur Biosynthese von spezifisch isotopenmarkierten Sekundärmetaboliten
BR112016008697B8 (pt) Método para produzir halocetonas

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: CERENIS THERAPEUTICS HOLDING SA (FR)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements